跳至正文
佰默生物 项目咨询
首页/SIMOA/Assay Kits

SIMOA / ASSAY

NEUROLOGY 4-PLEX E (Aβ40, Aβ42, GFAP, Nf-L)

Simoa® Neurology 4-Plex E 是一款用于神经退行性疾病和脑损伤研究的超敏多因子检测试剂盒,可在 EDTA 血浆和脑脊液样本中同时检测 Aβ40、Aβ42、GFAP 和 NfL 四个神经相关生物标志物。适用于阿尔茨海默病、神经损伤、药物研发和临床转化研究中的低丰度蛋白检测。 The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are amyloid beta 40 (Aβ40),…

NEUROLOGY 4-PLEX E (Aβ40, Aβ42, GFAP, Nf-L) 原有产品资料图
原有产品资料图 · 点击放大查看
查看完整产品简介
Simoa® Neurology 4-Plex E 是一款用于神经退行性疾病和脑损伤研究的超敏多因子检测试剂盒,可在 EDTA 血浆和脑脊液样本中同时检测 Aβ40、Aβ42、GFAP 和 NfL 四个神经相关生物标志物。适用于阿尔茨海默病、神经损伤、药物研发和临床转化研究中的低丰度蛋白检测。

询价 (Tel. 15750729215)

NEUROLOGY 4-PLEX E (Aβ40, Aβ42, GFAP*, Nf-L)

Neurology Panel

The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are amyloid beta 40 (Aβ40), amyloid beta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP), and Neurofilament light (NfL). With this Neuro 4-Plex E kit we introduce novel amyloid beta 40 and amyloid beta 42 assays developed for highly specific and sensitive measurement of the concentrations of full-length amyloid beta 1-42 and amyloid beta 1-40. This improved specificity for full-length amyloid beta 1-42 and amyloid beta 1-40 is expected to be increasingly important to target specific amyloid beta isoforms and for target engagement in future clinical trials.

*Banyan GFAP™ is a registered trademark of Banyan Biomarkers

产品说明

NEUROLOGY 4-PLEX E (Aβ40, Aβ42, GFAP*, Nf-L)

Neurology Panel

The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are amyloid beta 40 (Aβ40), amyloid beta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP), and Neurofilament light (NfL). With this Neuro 4-Plex E kit we introduce novel amyloid beta 40 and amyloid beta 42 assays developed for highly specific and sensitive measurement of the concentrations of full-length amyloid beta 1-42 and amyloid beta 1-40. This improved specificity for full-length amyloid beta 1-42 and amyloid beta 1-40 is expected to be increasingly important to target specific amyloid beta isoforms and for target engagement in future clinical trials.

*Banyan GFAP™ is a registered trademark of Banyan Biomarkers

Application and Intended Use

The Simoa® Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. Each biomarker has been demonstrated to have significance for the investigation of neurodegeneration and brain injury, and to have utility for monitoring effectiveness of drug discovery and development for neurological disease.

Compatible Instruments

Kit Contents

The assay kit includes all necessary reagents and controls to perform 96 tests, making it easy to use and compatible with various sample types.

资料下载

保留原有原厂资料入口。不同仪器与版本的参数,请逐一核对对应文件。

文献与引用

通过 Bioz 查看这款产品的引用文献、应用摘要与研究图片。

Bioz · 产品引用与应用文献在 Bioz 打开 ↗

Bioz 实时文献组件 · 可在组件内筛选和滚动浏览;无法载入时可在 Bioz 打开。

Powered by Bioz

您想从哪一步开始?

BIOMO / 站内搜索

你想找到什么?

从产品、科研服务到技术资料。

常用检索

单细胞VisiumDDA / DIASIMOAmIHCOlink

评估科研项目

留下研究目标和联系方式,便于进一步沟通。

不确定的项目可以留空,我们一起确认。

提交的信息将用于回复本次咨询,由佰默团队接收处理。

也可联系 panxu@biomobio.com